Accelerating identification and regulatory approval of investigational cancer drugs

JAMA. 2011 Dec 21;306(23):2608-9. doi: 10.1001/jama.2011.1837.
No abstract available

MeSH terms

  • Academic Medical Centers
  • Antineoplastic Agents*
  • Clinical Trials as Topic
  • Cooperative Behavior*
  • Drug Approval / organization & administration*
  • Drug Discovery / organization & administration*
  • Drug Industry
  • Federal Government
  • Humans
  • Interinstitutional Relations
  • Neoplasms / classification
  • Neoplasms / drug therapy
  • Pharmacogenetics
  • Time Factors
  • United States
  • United States Food and Drug Administration

Substances

  • Antineoplastic Agents